
News • Lentiviral vector-based approach
HPV-induced cancers: new vaccine candidate shows promise
A new onco-therapeutic vaccine candidate against human papillomavirus (HPV)-induced cancers, such as cervical and oropharyngeal cancers, has shown promising results in the preclinical phase.